Eslami Gharaati Maryam, Nahavandi Arezo, Baluchnejad Mojarad Torandokht, Roghani Mehrdad
Department of Physiology, School of Medicine, Iran University of Medical Science, Tehran, Iran.
Neuroscience Research Center, Iran University of Medical Science, Tehran, Iran.
Basic Clin Neurosci. 2020 Nov-Dec;11(6):781-793. doi: 10.32598/bcn.11.6.1657.1. Epub 2020 Nov 1.
Diabetic encephalopathy is described as any cognitive and memory impairments associated with hippocampal degenerative changes, including the neurodegenerative process and decreased number of living cells. Mitochondrial diabetes (MD) appears following activation of mutant mitochondrial DNA and is a combination of diabetes and cognitive deficit. In this research, we showed the correlation of diabetic encephalopathy, dysfunctional mitochondria, and changes in the expression of axonal transport proteins (KIF5b, Dynein).
Twenty-four male Wistar rats were divided into three groups: (n=8 in each group):1. Control + saline; 2. Diabetic, and 3. Diabetic + insulin. Before starting the experiments, the animals with blood sugar lower than 150 mg/dL entered the study. Diabetes induction was carried out by Intraperitoneal (IP) Streptozotocin (STZ) administration. Fasting Blood Sugar (FBS) and body weight was checked after the first week and at the end of the eighth week. Then, behavioral studies (elevated plus maze, Y-maze, and passive avoidance learning) were performed. After behavioral studies, blood samples were taken to measure serum insulin level and HgbA1c. Next, fresh hippocampal tissue was collected. Gene expression of motor proteins was assessed by real-time PCR and mitochondrial membrane potential by rhodamine123.
Our results showed the impairment of HgbA1c, serum insulin, FBS, and weight in the diabetic group (P<0.05). Behavioral tests revealed different degrees of impairment in diabetic rats (P<0.05). KIF5b mRNA expression increased in the hippocampus (P<0.05) with no change in dynein gene expression. These changes were associated with abnormal mitochondrial membrane potential (P<0.05).
KIF5b mRNA up-regulation in hippocampal neurons of STZ-diabetic rats is a factor that can be involved in abnormal axonal transport and decreased MMP, leading to impairment of mitochondrial function. These manifestations showed mitochondrial dysfunction in diabetes and resulted in abnormal behavioral tests and diabetic encephalopathy.
糖尿病性脑病被描述为与海马体退行性变化相关的任何认知和记忆障碍,包括神经退行性过程和存活细胞数量减少。线粒体糖尿病(MD)在突变线粒体DNA激活后出现,是糖尿病和认知缺陷的组合。在本研究中,我们展示了糖尿病性脑病、功能失调的线粒体与轴突运输蛋白(KIF5b、动力蛋白)表达变化之间的相关性。
将24只雄性Wistar大鼠分为三组(每组n = 8):1. 对照组 + 生理盐水;2. 糖尿病组;3. 糖尿病 + 胰岛素组。在开始实验前,血糖低于150 mg/dL的动物进入研究。通过腹腔注射链脲佐菌素(STZ)诱导糖尿病。在第一周和第八周结束时检查空腹血糖(FBS)和体重。然后,进行行为学研究(高架十字迷宫、Y迷宫和被动回避学习)。行为学研究后,采集血样以测量血清胰岛素水平和糖化血红蛋白(HgbA1c)。接下来,收集新鲜的海马组织。通过实时PCR评估运动蛋白的基因表达,通过罗丹明123评估线粒体膜电位。
我们的结果显示糖尿病组的糖化血红蛋白、血清胰岛素、空腹血糖和体重受损(P<0.05)。行为测试显示糖尿病大鼠存在不同程度的损伤(P<0.05)。海马体中KIF5b mRNA表达增加(P<0.05),而动力蛋白基因表达无变化。这些变化与线粒体膜电位异常有关(P<0.05)。
STZ诱导的糖尿病大鼠海马神经元中KIF5b mRNA上调是一个可能参与轴突运输异常和线粒体膜电位降低的因素,导致线粒体功能受损。这些表现显示糖尿病中线粒体功能障碍,并导致行为测试异常和糖尿病性脑病。